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Effect of recombinant human erythropoietin on endothelial cell apoptosis. duce apoptosis in various cell types. For instance, inter-
Background. Recombinant human erythropoietin (rHuEPO) induces leukin-3, insulin-like growth factor I and erythropoietin
endothelial cell growth and angiogenesis in vitro. The mechanisms are
inhibit apoptosis in the erythroid progenitor cells [5–7].unknown. Because an increase in endothelial cell survival could play
a role in this process, we examined the effect of rHuEPO on lipopoly- In addition, cultured endothelial cells undergo apoptosis
saccharide (LPS)-induced apoptosis in bovine pulmonary artery endo- when they are exposed to lipopolysaccharide (LPS), trans-
thelial cells (BPAECs).
forming growth factor b1, and hemorrhagic snake venomMethods. Four groups of cells were studied. The first group was
preincubated in serum-free medium followed by treatment with LPS. [8–11].
The second group was preincubated with rHuEPO followed by LPS. Erythropoietin is a 34,400 Da polypeptide growth fac-
The third group was treated with only rHuEPO. Control cells were
tor known to inhibit apoptosis in erythroid progenitors,cultured in the absence of rHuEPO and LPS. Apoptosis was deter-
mined by flow cytometric DNA analysis, propidium iodide staining, allowing more erythroid cells to proceed through various
cellular DNA fragmentation by ELISA, and gel electrophoresis. stages of proliferation and differentiation [12]. The eryth-
Results. LPS-treated cells showed an increase in hypodiploid DNA
ropoietin receptor has been recognized in endothelial(36.4 6 6.1%) compared with controls (9.8 6 3.3%, P , 0.001). Preincu-
bation with rHuEPO decreased this effect to 14.7 6 5.1% (P , 0.001). cells, and several authors have described different ac-
Apoptosis determined by propidium iodide was observed in 33 6 8% tions of recombinant human erythropoietin (rHuEPO)
of LPS-treated cells, but in only 9 6 3% of cells preincubated with
on the vascular endothelium [13–18]. Recently, we haverHuEPO cells (P , 0.001). Similarly, DNA fragmentation was de-
creased in rHuEPO pretreated cells compared with LPS alone (0.155 found that rHuEPO increases neovascular formation in
OD 6 0.02 vs. 0.538 6 0.09 OD, P , 0.001). DNA breakdown was vitro [19]. The mechanism of this effect is unknown, but
observed in only LPS-treated cells.
increased endothelial cell survival could play a role inConclusions. These results suggest that rHuEPO prevents LPS-
induced apoptosis in endothelial cells. This protective effect could be the angiogenetic process induced by rHuEPO.
an important factor in the action of rHuEPO on vascular endothelium. The aim of this study was to investigate the ability of
rHuEPO to suppress LPS-induced apoptosis in endothe-
lial cells in culture. Therefore, apoptosis was induced
Apoptosis, or programmed cell death, is a process by in bovine pulmonary aorta endothelial cells using LPS.
which cells participate in their own death. It is character- Apoptosis was analyzed by three different techniques
ized by cell shrinkage, chromatin condensation, and because there is not a single method to characterize this
DNA fragmentation [1]. This effect occurs in different process definitely.
physiological or pathological conditions and serves as a
balance between cell proliferation and cell death. The
METHODSpresence of apoptosis has been described in tissues with
rapid cell proliferation such as mammary tissue following Endothelial cell culture
weaning, during ovarian follicular atresia, and preneo- Bovine pulmonary artery endothelial cells (BPAECs)
plastic tissue [2–4]. Numerous factors may inhibit or in- from American Type Tissue Culture Collection (ATCC,
CCL-209; Rockville, MD, USA) were grown in minimum
essential medium (Sigma Chemical Co., St. Louis, MO,Key words: rHuEPO, lipopolysaccharide, cell growth, angiogenesis,
programmed cell death USA) supplemented with 20% fetal bovine serum (Sigma),
antibiotic free as previously described [16]. The cellsReceived for publication December 12, 1997
were platted into T25 flasks (Costar, Cambridge, MA,and in revised form August 28, 1998
Accepted for publication August 28, 1998 USA) at a density of 5 3 104. The medium was changed
twice a week. When cells confluence was achieved, the 1999 by the International Society of Nephrology
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medium was removed, and cells were washed twice with three times from separate batches of cells. The percent-
age of apoptotic cells was calculated as: the total numberserum-free medium (SFM). Cells were then incubated
under the experimental conditions described later here of cells with apoptotic nuclei/total number of cells
counted 3 100.to examine the effect of rHuEPO on cell apoptosis. Only
attached cells were used in all experiments.
Cellular DNA fragmentation
Experimental groups DNA fragmentation was determined using a commer-
cial kit “cellular DNA fragmentation ELISA” (Boeh-Four groups of BPAECs were cultured during 24
hours under different experimental conditions as follows. ringer Mannheim, Mannheim, Germany). This quantita-
tive assay uses two mouse monoclonal antibodies againstOne group was incubated for 20 hours in SFM followed
by the addition to the medium of LPS 100 ng/ml (sero- DNA and 5-bromo-2deoxy-uridine (BrdU), allowing the
specific detection and quantitation of BrdU-labeled DNAtype E. coli 0111:B4; Sigma) for four hours. Another
group was treated for 20 hours in SFM in the presence fragments. Confluent BPAECs were labeled with 10 mm
BrdU during 12 hours at 378C. Cells were then trypsin-of rHuEPO 100 U/ml (Epoetin Alfa; Amgen, Inc., Thou-
sand Oaks, CA, USA), followed by the addition to the ized and seeded onto 96-microwell plates (Costar). Lyzed
cells from each condition were transferred to anothermedium of LPS 100 ng/ml for four hours. A third group
of cells was incubated in SFM in the presence of rHuEPO 96-microwell plate that was previously fixed adsorptively
with a monoclonal mouse anti-DNA antibody. The im-alone (100 U/ml) for 24 hours without the addition of
LPS. The control group was incubated for 24 hours in munocomplex BrdU-labeled DNA fragments were de-
natured and fixed on the surface of the well by microwaveonly SFM (in the absence of rHuEPO and LPS). After
incubation under the different conditions, apoptosis was irradiation. Anti-BrdU peroxidase conjugate was added
to each well, and the amount of peroxidase bound todetermined using the techniques described later here.
Results represent mean 6 sd of three different experi- the immune complex was determined photometrically
at 370 nm. Results represent mean 6 sd of three differentments performed in duplicate.
experiments performed in duplicate.
Flow cytometric DNA analysis
Analysis of DNA breakdownOne-half to 1 3 106 BPAECs from each condition
were harvested by trypsin/ethylenediaminetetraacetic Five 3 106 BPAECs from each cell group were washed
with cold phosphate-buffered saline and were lyzed withacid (EDTA) and were centrifuged for five minutes at
200 3 g. The cell pellet was fixed in 2 ml ethanol 70% 500 ml of Tris-HCl 10 mm, pH 7.5, NaCl 10 mm, EDTA
1 mm, 1% SDS, and proteinase K 50 mg/ml (Sigma),at 48C for one hour. The cells were then centrifuged,
washed, resuspended in Hank’s balanced salt solution, followed by overnight incubation at 438C. DNA was ex-
tracted using 500 ml phenol, washed with choloform:isomiland incubated with 0.5 ml of 1 mg/ml RNAse (Type I-A;
Sigma). Cells were stained with 20 mg/ml propidium iodide alcohol (24:1), and incubated with RNase 50 mg/ml. DNA
overnight precipitation at 2208C was performed with 0.5(Sigma), and the fluorescence was measured using a flow
cytometer (Epics Elite ESP; Coulter, Miami, FL, USA). mm NaCl plus ethanol 95%. The pellets were resus-
pended in 50 ml distilled water, and the DNA concentra-A dose-response curve of rHuEPO on LPS-induced apo-
ptosis was performed by incubating BPAECs with differ- tion was determined from the absorbancy at 260 nm. Ten
micrograms of each sample were electrophoresed on aent concentrations of rHuEPO (0 to 200 U/ml) in the
presence or absence of LPS (100 ng/ml). Results repre- 1.5% agarose gel in Tris-borate buffer at 80 V for two
hours. DNA bands were visualized under ultraviolet lightsent mean 6 sd of three different experiments performed
in duplicate. after staining with ethidium bromide.
StatisticsMicroscopic analysis
Bovine pulmonary artery endothelial cells treated as All values are expressed as mean 6 sd. Statistical
analysis between multiple groups was carried out usingpreviously described were harvested by trypsin/EDTA
(Sigma) and were centrifuged at 200 3 g for three min- analysis of variance with the method of Bonferroni.
utes. The cell pellet was fixed in 2 ml of ethanol 70% at
48C for one hour. The cells were then centrifuged, washed,
RESULTS
resuspended with 0.5 ml phosphate-buffered saline, and
Flow cytometric analysesincubated with 0.5 ml of 1 mg/ml RNase (Type I-A;
Sigma). Cells were stained with 100 mg/ml propidium DNA content from the four groups of cells was evalu-
ated by flow cytometric analysis. This method can detectiodide (Sigma) and were observed under a fluorescent
microscopy. Fifty to 100 cells were counted and were nuclei with a lower than normal G1 staining intensity.
Apoptotic nuclei distinguished by hypodiploid DNA con-considered as N 5 1. All experiments were performed
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Microscopy
Figure 3A shows a photomicrograph of BPAECs cul-
tured during 20 hours in SFM followed by the addition
to the medium of LPS for four hours. Apoptotic morpho-
logical alterations characterized by nuclear condensa-
tion, cellular shrinkage, and tendency toward clumping
were present in 33 6 8% (Fig. 3A) of the cells compared
with control cells that were cultured in the absence of
rHuEPO and LPS (11 6 4%, P , 0.001; Fig. 3C). In
contrast, cells cultured in the presence of rHuEPO for
20 hours followed by LPS for four hours resulted in a
significant decrease in apoptosis (9 6 3%, P , 0.001;
Fig. 3B).
Measurement of cellular apoptosis by ELISAFig. 1. Effect of increasing concentrations of recombinant human
erythropoietin (rHuEPO) on lipopolysaccharide (LPS)-induced apo- Figure 4 demonstrates that the addition of LPS to
ptosis. The percentage of apoptotic cells was measured by flow cytome- BPAECs cultured in SFM induced a significant increasetric DNA analysis. Cells were treated with the indicated concentrations
in apoptosis when compared with controls in the absenceof rHuEPO for 24 hours in the absence of LPS ( ). Cells were incubated
at increasing concentration of rHuEPO (0 to 200 U/ml) for 20 hours of LPS (0.538 6 0.09 vs. 0.176 6 0.01 OD, respectively,
followed by the addition to the medium of LPS (100 ng/ml) during P , 0.001). In contrast, when BPAECs were preincu-four hours ( ). Results represent the mean 6 sd of three different
bated in the presence of rHuEPO for 20 hours prior toexperiments performed in duplicate. *LPS (100 ng/ml) versus rHuEPO
(0 U/ml; P , 0.001). **LPS (100 ng/ml) versus LPS 1 rHuEPO (100 the addition of LPS, apoptosis was inhibited as compared
U/ml; P , 0.001). ***LPS (100 ng/ml) versus LPS 1 rHuEPO (200 U/ with cells incubated with LPS in the absence of rHuEPOml; P , 0.01).
(0.155 6 0.02 vs. 0.538 6 0.09 OD, respectively, P ,
0.001).
DNA fragmentation assaytent are located in the sub-G1 phase. Figure 1 shows a
Apoptosis is characterized by a specific DNA break-dose-response curve for the inhibitory effect of rHuEPO
down leading to a cellular DNA ladder after electro-on LPS-induced apoptosis. Cells were incubated at in-
phoresis. Figure 5 shows the results of agarose gel elec-creasing concentrations of rHuEPO (0 to 200 U/ml) in
trophoresis of DNA from BPAECs treated under thethe presence or absence of LPS (100 ng/ml). In the ab-
different conditions. Molecular weights are depictedsence of rHuEPO or LPS, there was a basal apoptosis
in lane 1. Cells cultured in SFM for 20 hours followedof 8.7 6 2.3%. In contrast, cells treated with LPS alone
by incubation for four hours in the presence of LPSshowed a significant increase in apoptosis (34.8 6 5.6%,
showed DNA fragmentation (lane 2). Cell incubated withP , 0.001). Incubation only with rHuEPO at the differ-
rHuEPO alone (lane 3) or with SFM alone (lane 4) dident concentrations did not significantly affect the base-
not exhibit DNA breakdown. However, cells pretreatedline level. Incubation of cells in the presence of rHuEPO
with rHuEPO and then incubated with LPS showed aresulted in inhibition of LPS-induced apoptosis. The effect
light DNA fragmentation (lane 5).was maximal at an rHuEPO concentration of 100 U/ml
(13.2 6 4.3%) as compared with cells treated with only
LPS (34.8 6 5.6%, P , 0.001). Increasing the concentra- DISCUSSION
tion of rHuEPO to 200 U/ml did not inhibit apoptosis In this study, we have examined the effect of rHuEPO
further. on endothelial cell survival. Our results show that rHuEPO
Figure 2 depicts the measurement of cellular apoptosis decreases LPS-induced apoptosis in cultured BPAECs.
in the different groups of BPAECs. Control cells showed This effect occurs in a dose-dependent fashion. In the
9.8 6 3.3% of apoptosis (Fig. 2A). No difference was absence of LPS, rHuEPO had no effect on apoptosis,
found between controls and cells treated with only indicating that the rHuEPO-protective effect is exerted
rHuEPO for 24 hours (12 6 4.1%; Fig. 2B). In contrast, exclusively in LPS-treated cells. Furthermore, neither
a significant increase in hypodiploid DNA was detected high rHuEPO concentrations nor serum deprivation af-
in LPS-treated cells 36.4 6 6.1% (Fig. 2C) as compared fected cell viability.
with controls 9.8 6 3.3% (P , 0.001; Fig. 2A). Preincuba- The mechanism whereby rHuEPO decreases LPS-
tion with rHuEPO significantly decreased the LPS- induced apoptosis in endothelial cells is unknown. The
induced apoptosis to 14.7 6 5.1% (Fig. 2D) as compared fact that the protective effect is observed only when
the hormone is added prior to the incubation with LPSwith cells treated with only LPS (P , 0.001; Fig. 2C).
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Fig. 2. Flow cytometric analysis of bovine pulmonary artery endothelial cells (BPAECs) treated as follows: serum free medium (SFM) for 24
hours (A), only recombinant human erythropoietin (rHuEPO; 100 U/ml) 24 hours (B), SFM for 20 hours followed by the addition to the medium
of lipopolysaccharide (LPS; 100 ng/ml) during four hours (C), and cells cultured for 20 hours with rHuEPO followed by the addition to the medium
of LPS for four hours (D). Results represent the mean 6 sd of three different experiments performed in duplicate.
suggests that rHuEPO may interfere or retard the ex- apoptosis in bovine endothelial cell via a soluble CD14-
dependent mechanism [20].pression of proteins involved in the regulation of apopto-
sis induced by this agent. In favor of this possibility, Inhibition of apoptosis by rHuEPO has also been dem-
onstrated in erythroid cell progenitors. Recent studiesin our preliminary experiments, the inhibitory effect of
rHuEPO was not clearly observed when cells were incu- have shown that rHuEPO-deprived murine proerythro-
blasts undergo apoptosis. This effect does not requirebated concurrently with LPS along the entire duration of
the experiment. Recent studies suggest that LPS induces cell cycle arrest and is not associated with conformational
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Fig. 3. Photomicrograph of BPAECs stained with propidium iodide.
(A) Cells cultured for 20 hours in serum free medium (SFM) followed
by the addition to the medium of lipopolysaccharide (LPS; 100 ng/ml)
for four hours. (B) Cells cultured with recombinant human erythropoietin
(rHuEPO; 100 U/ml) for 20 hours followed by the addition to the medium
of LPS during four hours. (C) Control cells cultured during 24 hours
in SFM. Fifty to 100 cells were counted and considered as N 5 1. All
experiments were performed three times from separate batches of cells.
The percentage of apoptotic cells was calculated as follows: the total
number of cells with apoptotic nuclei/total number of cells counted 3 100.
changes or stabilization of wild-type p53 protein [21]. kine signaling that may be involved in the inhibition
of apoptosis [22]. In fact, rHuEPO can induce tyrosineMoreover, rHuEPO can prevent apoptosis by induction
of c-Jun and through the expression of Bcl-XL and Bcl-2 phosphorylation of six different proteins, including a
transcription factor, STAT-5.oncogenes [22]. A study by Haller et al using endothelial
cells has demonstrated that rHuEPO could trigger cyto- Because of the reports of Anagnostou et al indicating
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Fig. 4. ELISA quantitation of cellular DNA fragmentation from
BPAECs treated as follows: (h) 24 hours of incubation in SFM; ( )
24 hours of incubation with rHuEPO 100 U/ml; ( ) 20 hours in SFM
followed by the addition to the medium of LPS (100 ng/ml) during four
hours; and ( ) 20 hours of incubation with rHuEPO followed by the
addition to the medium of LPS for four hours. Results represent the
mean 6 sd of three different experiments performed in duplicate. LPS
(100 ng/ml) versus *LPS 1 rHuEPO (100 U/ml) (P , 0.001).
Fig. 5. Representative gel electrophoresis
analysis of DNA extracted from BPAECs.
Lane 1, molecular weights. Lane 2, cells treated
with SFM for 20 hours followed by the addition
to the medium of LPS (100 ng/ml) for four
hours. Lane 3, cells incubated for 24 hours
with only rHuEPO. Lane 4, cells incubated
for 24 hours with only SFM. Lane 5, cells
incubated for 20 hours with rHuEPO (100 U/
ml) followed by the addition to the medium
of LPS during four hours. Similar results were
observed in four additional experiments.
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Haematopoietic colony stimulating factors promote cell survivalthat endothelial cells have erythropoietin receptors [13,
by suppressing apoptosis. Nature 343:76–79, 1990
14], several studies have shown that rHuEPO interacts 6. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST:
Human colony-forming units-erythroid do not require accessorywith the vascular endothelium. It has been demonstrated
cells, but do require direct interaction with insulin-like growththat rHuEPO has a direct vasoconstrictor effect and in-
factor I and/or insulin for erythroid development. J Clin Invest
duces smooth muscle cell proliferation and endothelin-1 83:1701–1709, 1989
7. Koury MJ, Bondurant MC: Erythropoietin retards DNA break-secretion [15–18]. Also, rHuEPO stimulates endothelial
down and prevents programmed death in erythroid progenitorcell migration and proliferation [13, 17]. Previous studies
cells. Science 248:378–381, 1990
from Carlini et al have demonstrated that rHuEPO pro- 8. Harlan JM, Harker LA, Reidy MA, Gajdusek CM, Schwartz
SM, Striker GE: Lipopolysaccharide-mediated bovine endothelialmotes neovascularization in cultured aortic rings from
cell injury in vitro. Lab Invest 48:3269–3274, 1983rats [19]. The genesis of this effect is unclear; however,
9. Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, Lazo JS: Collagen
it seems possible that endothelial cell survival could play is a survival factor against LPS-induced apoptosis in cultured sheep
pulmonary endothelial cells. Am J Physiol 269(Lung Cell Mola role in the neovascularization process. Indeed, inhibi-
Physiol 13):L171–L177, 1995tion of capillary morphogenesis is associated with endo-
10. Tsukada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Mat-
thelial cell apoptosis [23, 24]. Consequently, it is feasible suoka N, Takashima H, Mizokami A, Nagataki S: Transforming
growth factor b1 induces apoptotic cell death in cultured humanthat the decrease in apoptosis induced by rHuEPO could
endothelial cells with down-regulated expression of BCL-2. Bio-play a role in the neovascularization process.
chem Biophys Res Commun 210:1076–1082, 1995
The rHuEPO-protective action may have a further 11. Araki S, Ishida T, Yamamoto T, Kaji K, Hayashi H: Induction
of apoptosis by hemorrhagic snake venom in vascular endothelialimpact on the vascular endothelium. Several reports
cells. Biochem Biophys Res Commun 190:148–153, 1993have demonstrated a deleterious effect of uremia or he-
12. Koury MJ, Boudurant MC: Maintenance by erythropoietin of
modialysis on endothelial cell function. Activation and viability and maturation of murine erythroid precursor cells. J Cell
Physiol 137:65–74, 1988dysfunction of endothelial cells are present in end-stage
13. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M:renal disease [25]. Studies using endothelial cell lesion
Erythropoietin has a mitogen and positive chemotactic effect on
markers have shown that hemodialysis may cause injury endothelial cells. Proc Natl Acad Sci USA 87:5978–5982, 1990
14. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimianin these cells [26, 27]. At the same time, there is evidence
N, Noguchi CT: Erythropoietin receptor mRNA expression inthat hemodialysis patients could develop a dermal angio-
human endothelial cells. Proc Natl Acad Sci USA 91:3974–3978,
pathy, characterized by endothelial cell proliferation and 1994
15. Heidenreich S, Rahn KH, Zidek W: Direct vasopressor effectnew capillary formation [28]. Finally, Kuriyama et al’s
of recombinant human erythropoietin on renal resistance vessels.recent study may support our findings [29]. These authors
Nephrol Dial Transplant 5:739–740, 1990
have demonstrated that in patients with chronic renal 16. Ammarguellat F, Gogusev J, Drueke TB: Direct effect of eryth-
ropoietin on rat vascular smooth-muscle cell via a putative erythro-failure, intravenous rHuEPO improves the endothelial
poietin receptor. Nephrol Dial Transplant 11:687–692, 1996cell dysfunction caused by the uremia.
17. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M:
In conclusion, our results suggest that rHuEPO could Recombinant human erythropoietin (rHuEPO) increases endo-
thelin-1 release by endothelial cells. Kidney Int 43:1010–1014, 1993act as a survival factor increasing the viability of the
18. Nagay T, Akizawa T, Nakashima Y, Kohjiro S, Nabeshima K,injured endothelial cells.
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